Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2009
12/03/2009CA2723267A1 Semiconductor materials and methods of preparation and use thereof
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/03/2009CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof
12/03/2009CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof
12/02/2009EP2128160A1 Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents
12/02/2009EP2128159A1 Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device
12/02/2009EP2125809A1 Imidazopyridine inhibitors of iap
12/02/2009EP2125807A2 Imidazo[1,2-a]pyrrolo[3,2-c]pyridine compounds useful as pestivirus inhibitors
12/02/2009EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
12/02/2009EP2125801A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
12/02/2009EP2125738A1 Immune response modifier compositions and methods
12/02/2009EP2125724A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists
12/02/2009EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
12/02/2009EP2124943A1 Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
12/02/2009EP2124560A1 2-aminopyrimidine modulators of the histamine h4 receptor
12/02/2009EP2054412B1 Imino-imidazo-pyridine derivatives having antithrombotic activity
12/02/2009EP1902046B1 Piperidine derivatives useful as histamine h3 antagonists
12/02/2009EP1838805B1 Orthogonally fixed compounds for electrooptical applications
12/02/2009EP1737859B1 Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0 nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
12/02/2009EP1694677B1 Spiropiperidine derivatives for controlling pests
12/02/2009EP1542684B1 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
12/02/2009CN101595109A 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
12/02/2009CN101595108A Novel compound having affinity for amyloid
12/02/2009CN101595102A Biaryl ether urea compounds
12/02/2009CN101595100A Heterocyclic-substituted piperidine as ORL-1 ligands
12/02/2009CN101594866A Topical formulations
12/02/2009CN101591337A Compound formed by splicing ferulic acid and matrine compound and application thereof
12/02/2009CN101591336A Method for reducing 8-benzyl-2,8-diazabicyclo[4,3,0]nonane and chiral isomer thereof
12/02/2009CN101591335A N-(L-aminoacyl)-1, 2, 3, 4-tetrahydrochysene carboline acyl aminoacid benzyl ester, synthetic method and application thereof
12/02/2009CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/02/2009CN100564379C Pyrrolo[3,2-C]pyridine derivatives and processes for the preparation thereof
12/02/2009CN100563653C Heterocyclic compounds which are active as inhibitors of beta lactamases
12/01/2009US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
12/01/2009US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7626027 phosphorylation activity; CNS mood disorders (major depressive disorder, bipolar I and II disorders), sleep disorders (circadian rhythm - shift work, jet lag), advanced and delayed sleep phase; reaction of a chloronitropyridine and diethyl malonate; decarboxylation, cyclization
12/01/2009US7626026 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
12/01/2009US7626025 Isolated from Indian ascidian Synoicum macroglossum by solvent extraction; chromatography; for treatment of diabetic disorders by providing inhibition of alpha (alpha)glucosidase
12/01/2009US7626021 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
12/01/2009US7626019 Antiproliferative agents
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625930 Chromophoric moiety comprises trialkoxyphenylpyridyl groups; biochemical conjugation; for solid phase synthesis of oligonucleotides and oligopeptides; magnetic resonance imaging; positron emission tomography
12/01/2009US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same
12/01/2009US7625923 -4-[7-(hydroxy)-tetrahydro-pyrrolo[1,2-c]oxazol-3-ylideneamino]-2-chloro-3-methyl-benzonitrile; non-steroidal, non-toxic; side effect reduction; aging resistance; sarcopenia, osteoporosis and osteopenia, osteoporosis and osteopenia, cancer cachexia, eating disorders (e.g., anorexia) and chemotherapy
12/01/2009US7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
12/01/2009US7625921 Bridged ring compounds based on nitrogen-containing rings such as 5,10-dihydro-5,10-ethanobenzo(g)quinoline; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor
12/01/2009US7625895 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase
12/01/2009US7625890 Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
12/01/2009US7625888 {(1R)-1-(2,4,5-Trifluorobenzyl)-2-[9-(trifluoromethyl)-5,6-dihydrobis[1,2,4]triazolo[1,5-a:3',4'-c]pyrazin-3-yl]ethyl}amine, hydrochloride; metformin; treating non-insulin dependent (Type 2) diabetes in a mammal
12/01/2009US7625497 Providing solutions containing selected concentrations of soluble orienting compounds in an isotropic phase or in a lyotropic liquid-crystalline phase, introducing solutions into template having at least one dimension that is micro- or nanoscaled, removing sufficient solvent to form anisotropic solid
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143477A1 Heterocycles as protein kinase inhibitors
11/26/2009WO2009143445A1 Aza-beta-carbolines and methods of using same
11/26/2009WO2009143347A2 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
11/26/2009WO2009143156A2 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
11/26/2009WO2009141399A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009WO2009141398A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009WO2009141159A1 2,5-disubstituted imidazo[4,5-c]pyridines for treating muscular dystrophy
11/26/2009WO2009123948A3 Compounds and compositions as itpkb inhibitors
11/26/2009WO2009076440A4 Fungicidal bicyclic pyrazoles
11/26/2009US20090291978 Enzyme Inhibitors
11/26/2009US20090291977 Chromane Derivatives Useful As Acid Pump Antagonists
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291958 Substituted PDE5 inhibitors
11/26/2009US20090291946 Lactam compounds and their use as pharmaceuticals
11/26/2009US20090291942 Imidazo pyridine derivatives
11/26/2009US20090291941 Tyrosine Kinase Inhibitors
11/26/2009US20090291937 Kinase inhibitors
11/26/2009US20090291921 Integrase inhibitors
11/26/2009US20090288707 Novel compounds for electronic material and organic electronic device using the same
11/26/2009CA2725726A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009CA2724842A1 Imidazo[1,2-a]pyridine compounds
11/26/2009CA2724715A1 Heterocycles as protein kinase inhibitors
11/26/2009CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/26/2009CA2688469A1 2,5-disubstituted imidazo[4,5-c]pyridines for treating muscular dystrophy
11/25/2009EP2123652A1 Heterocyclic compound
11/25/2009EP2123651A1 Condensed pyridine compound
11/25/2009EP2123638A1 Metal complex
11/25/2009EP2121686A1 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor
11/25/2009EP2121683A2 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
11/25/2009EP2121681A1 Compounds and method for treatment of cancer
11/25/2009EP2121680A1 A novel and economical process for preparing (s,s)-2, 8-diazabicycloý4.3.0¨nonane and its enantiomer
11/25/2009EP2121648A2 S1p receptor modulating compounds and use thereof
11/25/2009EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009EP2120951A1 Inhibitors of akt activity
11/25/2009EP2120938A1 Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
11/25/2009EP2120935A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
11/25/2009EP2120933A1 Isoquinolinopyrrolopyridinones active as kinase inhibitors
11/25/2009EP2120573A1 Piperidine derivatives
11/25/2009EP1963318B1 Pyrrolo[2,3-c]pyridine derivatives
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 646